Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025

1 min
With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday.

No comments yet.

Back to feed